Weight loss injection boosts Danish economic growth. The company Novo Nordisk has become the most valuable company in Europe thanks to its weight loss syringes.
According to one forecast, the boom is likely to affect the entire Danish economy in 2024. The country's largest bank, Danske Bank, predicts that Denmark's gross domestic product will grow by 2.1 percent. This is largely due to the manufacturer of the diabetes drug Ozempic and the weight loss drug Wegovy.